Barclays PLC Omeros Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Omeros Corp stock. As of the latest transaction made, Barclays PLC holds 94,640 shares of OMER stock, worth $836,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,640

Previous 94,640 -0.0%

Holding current value

$836,617

Previous $376,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$3.54 - $5.47 $183,630 - $283,745	51,873 Added 121.29%	94,640 $376,000
Q2 2024 Aug 14, 2024	SELL	$3.04 - $4.23 $106,023 - $147,525	-34,876 Reduced 44.92%	42,767 $173,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.89 $117,573 - $199,629	-40,824 Reduced 34.46%	77,643 $268,000
Q4 2023 Feb 15, 2024	BUY	$1.08 - $3.63 $78,665 - $264,401	72,838 Added 159.63%	118,467 $387,000
Q3 2023 Nov 07, 2023	BUY	$2.81 - $5.69 $43,431 - $87,944	15,456 Added 51.22%	45,629 $134,000
Q2 2023 Aug 03, 2023	SELL	$4.45 - $7.57 $223,536 - $380,263	-50,233 Reduced 62.47%	30,173 $163,000
Q1 2023 May 04, 2023	BUY	$2.48 - $5.22 $124,865 - $262,821	50,349 Added 167.51%	80,406 $374,000
Q4 2022 Feb 13, 2023	BUY	$1.75 - $3.96 $46,278 - $104,722	26,445 Added 732.14%	30,057 $68,000
Q3 2022 Nov 03, 2022	SELL	$3.09 - $7.46 $36,502 - $88,124	-11,813 Reduced 76.58%	3,612 $11,000
Q2 2022 Aug 12, 2022	SELL	$1.92 - $6.28 $10,798 - $35,318	-5,624 Reduced 26.72%	15,425 $42,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $396,306 - $562,802	-78,167 Reduced 78.78%	21,049 $127,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $349,827 - $526,900	61,698 Added 164.45%	99,216 $637,000
Q3 2021 Nov 09, 2021	BUY	$13.4 - $16.3 $244,241 - $297,100	18,227 Added 94.48%	37,518 $517,000
Q2 2021 Aug 13, 2021	SELL	$14.81 - $19.13 $581,677 - $751,349	-39,276 Reduced 67.06%	19,291 $286,000
Q1 2021 May 13, 2021	BUY	$14.52 - $23.53 $496,206 - $804,114	34,174 Added 140.1%	58,567 $1.04 Million
Q4 2020 Feb 11, 2021	SELL	$10.14 - $15.19 $198,013 - $296,630	-19,528 Reduced 44.46%	24,393 $349,000
Q3 2020 Nov 12, 2020	BUY	$9.57 - $21.32 $65,659 - $146,276	6,861 Added 18.51%	43,921 $444,000
Q2 2020 Aug 12, 2020	BUY	$12.21 - $16.99 $152,747 - $212,544	12,510 Added 50.96%	37,060 $546,000
Q1 2020 May 13, 2020	SELL	$9.03 - $19.72 $221,316 - $483,317	-24,509 Reduced 49.96%	24,550 $329,000
Q4 2019 Feb 10, 2020	SELL	$13.01 - $17.15 $592,098 - $780,513	-45,511 Reduced 48.12%	49,059 $691,000
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $277,352 - $391,914	19,062 Added 25.25%	94,570 $1.54 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $927,240 - $1.21 Million	61,816 Added 451.48%	75,508 $1.19 Million
Q1 2019 May 15, 2019	BUY	$11.65 - $17.72 $156,296 - $237,731	13,416 Added 4860.87%	13,692 $238,000
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $481,606 - $751,611	-44,926 Reduced 99.39%	276 $3,000
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $387,613 - $583,496	21,862 Added 93.67%	45,202 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$10.79 - $24.44 $11,307 - $25,613	1,048 Added 4.7%	23,340 $424,000
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $122,805 - $275,083	13,645 Added 157.8%	22,292 $248,000
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $36,239 - $62,476	2,733 Added 46.21%	8,647 $168,000
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $116,860 - $147,258	5,914	5,914 $128,000

Others Institutions Holding OMER

# of Institutions

121

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $555M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account